[{"address1": "Bynet Building", "address2": "3rd Floor 19 Hartum Street Har Hotzvim", "city": "Jerusalem", "zip": "9777518", "country": "Israel", "phone": "972-2-582-4030", "website": "https://www.brainsway.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.", "fullTimeEmployees": 134, "companyOfficers": [{"maxAge": 1, "name": "Mr. Hadar  Levy", "age": 49, "title": "Chief Executive Officer", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 434000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Avner  Hagai", "age": 67, "title": "Founder & Director", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 43646, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Abraham  Zangen", "age": 53, "title": "Co-Founder, Member of Scientific Advisory Board & Director", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 72175, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yiftach  Roth Ph.D.", "age": 52, "title": "Founder & Chief Scientific Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 108000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ido  Marom", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1976, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gilead  Moiseyev", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Menachem C. Klein Esq.", "title": "VP, General Counsel & Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ross  Mitchell", "title": "Vice President of Global Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hillegonda  Groen", "age": 54, "title": "Vice President of International Sales", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Richard A. Bermudes M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://www.brainsway.com/Brainsway/Templates/ShowPage.asp?DBID=1&LNGID=1&TMID=84&FID=540", "maxAge": 86400, "priceHint": 2, "previousClose": 9.32, "open": 9.28, "dayLow": 9.25, "dayHigh": 9.74, "regularMarketPreviousClose": 9.32, "regularMarketOpen": 9.28, "regularMarketDayLow": 9.25, "regularMarketDayHigh": 9.74, "beta": 0.375, "trailingPE": 480.00003, "forwardPE": 137.14287, "volume": 173996, "regularMarketVolume": 173996, "averageVolume": 93157, "averageVolume10days": 94940, "averageDailyVolume10Day": 94940, "bid": 9.47, "ask": 9.62, "bidSize": 100, "askSize": 100, "marketCap": 161495040, "fiftyTwoWeekLow": 3.09, "fiftyTwoWeekHigh": 10.0, "priceToSalesTrailing12Months": 4.432902, "fiftyDayAverage": 8.1488, "twoHundredDayAverage": 6.59315, "currency": "USD", "enterpriseValue": 231736000, "profitMargins": 0.01669, "floatShares": 22271100, "sharesOutstanding": 16678100, "sharesShort": 28986, "sharesShortPriorMonth": 49183, "sharesShortPreviousMonthDate": 1724976000, "dateShortInterest": 1727654400, "sharesPercentSharesOut": 0.0017, "heldPercentInstitutions": 0.2212, "shortRatio": 0.35, "shortPercentOfFloat": 0.0025, "impliedSharesOutstanding": 16658600, "bookValue": 1.433, "priceToBook": 6.6992326, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": 608000, "trailingEps": 0.02, "forwardEps": 0.07, "enterpriseToRevenue": 6.361, "enterpriseToEbitda": 132.269, "52WeekChange": 1.7411764, "SandP52WeekChange": 0.3593408, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "BWAY", "underlyingSymbol": "BWAY", "shortName": "Brainsway Ltd.", "longName": "BrainsWay Ltd.", "firstTradeDateEpochUtc": 1555507800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "4b7576e5-11f7-3ea0-a827-d2fc22b2b272", "messageBoardId": "finmb_34280817", "gmtOffSetMilliseconds": -14400000, "currentPrice": 9.6, "targetHighPrice": 16.0, "targetLowPrice": 10.0, "targetMeanPrice": 12.78, "targetMedianPrice": 12.55, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 47864000, "totalCashPerShare": 1.595, "ebitda": 1752000, "quickRatio": 4.241, "currentRatio": 4.7, "totalRevenue": 36431000, "revenuePerShare": 2.152, "returnOnAssets": 0.0073100002, "returnOnEquity": 0.01442, "freeCashflow": 3162875, "operatingCashflow": 8356000, "revenueGrowth": 0.278, "grossMargins": 0.74824, "ebitdaMargins": 0.04809, "operatingMargins": 0.058569998, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-17"}]